Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach

João G Costa1, Nuno Saraiva2, Patrícia S Guerreiro3

  • 1CBIOS, Universidade Lusófona Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal; Department of Biomedical Sciences, University of Alcalá, Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain.

Insights

Ochratoxin A (OTA) causes kidney cell damage and DNA lesions, partly due to reactive oxygen species (ROS). A superoxide dismutase mimic (SODm) reduced these OTA-induced effects, suggesting oxidative stress involvement.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Cell Biology

Background:

  • Ochratoxin A (OTA) is a nephrotoxic and potentially carcinogenic mycotoxin.
  • The precise molecular mechanisms behind OTA's toxicity remain unclear.
  • Investigating the role of reactive oxygen species (ROS) is crucial for understanding OTA's effects.

Purpose of the Study:

  • To investigate the toxicological effects of Ochratoxin A (OTA) in Vero kidney cells.
  • To elucidate the contribution of reactive oxygen species (ROS) to OTA-induced toxicity.
  • To utilize a superoxide dismutase mimic (SODm) as a tool to assess oxidative stress involvement.

Main Methods:

  • Cytotoxicity assays (crystal violet, neutral red, LDH leakage).
  • Genotoxicity assessment (micronuclei formation, comet assay).
  • Apoptosis evaluation and ROS detection (DHE assay) with and without SODm.

Main Results:

  • OTA exhibited concentration- and time-dependent cytotoxicity and genotoxicity.
  • OTA induced DNA lesions and apoptosis, which were partially attenuated by SODm.
  • SODm reduced ROS accumulation, indicating partial involvement of oxidative stress.

Conclusions:

  • Reactive oxygen species (ROS) partially mediate Ochratoxin A's cytotoxicity and genotoxicity.
  • Other mechanisms likely contribute to OTA's overall deleterious effects.
  • Superoxide dismutase mimics show potential in mitigating OTA-induced oxidative stress.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
109
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.8K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
162
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.4K